Campbell Newman Asset Management »

Catalyst Pharmaceutical Partners shares owned by Campbell Newman Asset Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Campbell Newman Asset Management from 13F filings

Historical chart of Campbell Newman Asset Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Campbell Newman Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Campbell Newman Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 90k 15.94

More positions owned by Campbell Newman Asset Management

Microsoft Corp. Common Stocks (MSFT)
Apple Common Stocks (AAPL)
Broadcom Common Stocks (AVGO)
KLA Corp. Common Stocks (KLAC)
Eli Lilly & Co. Common Stocks (LLY)
Analog Devices Common Stocks (ADI)
Stryker Corp. Common Stocks (SYK)
ConocoPhillips Common Stocks (COP)
Lowe's Companies Common Stocks (LOW)
Visa, Inc. Class A Common Stocks (V)
Merck & Co Common Stocks (MRK)
Mastercard Common Stocks (MA)
Arthur J. Gallagher & Co. Common Stocks (AJG)
Emerson Electric Common Stocks (EMR)
TE Connectivity Ltd. Regular S Common Stocks (TEL)

View all positions for Campbell Newman Asset Management

Top funds holding Catalyst Pharmaceutical Partners

Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
LSV Asset Management
T. Rowe Price Associates
Henderson Group
Goldman Sachs Group
Charles Schwab Investment Management
Jupiter Asset Management
Bank of New York Mellon
Bank of America Corporation

View all funds holding Catalyst Pharmaceutical Partners